Samsung Biologics and Ligachem Biosciences will expand their collaboration on projects to develop antibody-drug conjucates ...

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced to ...

Shares rose more than 1 percent Wednesday, driven by advances in top-cap Samsung Electronics and other tech shares.

Biologics for rheumatoid arthritis (RA) are generally quick-acting and effective, but their effectiveness and the time it takes to see results can vary. Many are FDA approved, including adalimumab ...

The investment was made through the Samsung Life Science Fund, which was created jointly between Samsung Biologics, Samsung C&T, and Samsung Bioepis, and managed by Samsung Venture Investment ...

which was created jointly between Samsung Biologics, Samsung C&T, and Samsung Bioepis, and managed by Samsung Venture Investment Corporation. Established in 2021 and worth KRW 240 billion ...

“We see great potential in Generate to develop first- and best-in-class therapeutics,” said John Rim, President and CEO of Samsung Biologics. “Leveraging Generate’s strengths in AI and machine ...

“We see great potential in Generate to develop first- and best-in-class therapeutics,” said John Rim, President and CEO of Samsung Biologics. “Leveraging Generate’s strengths in AI and machine ...

Samsung Biologics announced on the 17th that it has signed a contract for contract manufacturing organization (CMO) with a U.S. pharmaceutical company. The contract size is 111.2 billion won ...

Samsung Biologics was recognized for its dedication to embed sustainable business practices across its operations, particularly robust environmental efforts, including progress toward achieving ...